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Abstract: White muscle disease (WMD) is a world-wide nutritional disease of all animal species characterised by degeneration of
skeletal and cardiac muscles. In the present study we determined the cardiac troponin I (cTnI) and inducible nitric oxide synthase
(iNOS) expression in hearts of the lambs with WMD (n = 15). Eight clinically healthy lambs served as control. Creatine kinase (CK),
creatine kinase MB (CK-MB), aspartate aminotransferase (AST), and lactate dehydrogenase (LDH) activities were analysed for both
groups. cTnI levels were measured by a commercially available ELISA kit. Mean cTnI (10.49 ± 0.25 ng/ml), CK (261.16 ± 38.61
U/l), CK-MB (214.16 ± 12.71 U/l), AST (125.83 ± 1.05), and LDH (228.77 ± 14.86 U/l) concentrations were higher in WMD cases.
Immunohistochemistry revealed definitive loss of cTnI expression in all cases. None of the 8 controls showed loss of the cTnI
expression. However, iNOS immunoreactivity was augmented in degenerated cardiac myocytes and macrophages infiltrating to the
interstitium compared to controls. The results of the study suggested that cTnI antibody might successfully be used as a sensitive
test in the diagnosis of myocardial injury. iNOS expression augments in cardiac myocytes in lambs with WMD, most likely through
influencing the signalling pathways to iNOS induction.
Key Words: White muscle disease, lamb, immunohistochemistry, cTnI, iNOS

Kuzulardaki Beyaz Kas Hastalığında Kardiyak Troponin I ve İndüklenebilir
Nitrik Oksit Sentetaz Ekspresyonunun Değerlendirilmesi
Özet: Hayvanlardaki beyaz kas hastalığı (WMD) iskelet ve kalp kasında dejenerasyonla karakterize oldukça yaygın nutrisyonel bir
hastalıktır. Çalışmada WMD tanısı konulan (n = 15) ve klinik olarak sağlıklı (n = 8) kuzuların kalp kasındaki kardiyak troponin I (cTnI)
ve indüklenebilir nitric oksit sentetaz (iNOS) ekspresyonları araştırıldı. Kreatin kinaz (CK), kreatin kinaz MB (CK-MB), aspartat
aminotransferaz (AST) ve laktat dehidrogenaz (LDH) aktiviteleri de her iki grupta değerlendirildi. Ayrıca serum cTnI seviyeleri de ticari
ELISA kiti ile belirlendi. WMD olgularında ortalama serum cTnI (10,49 ± 0,25 ng/ml), CK (261,16 ± 8,61 U/l), CK-MB (214,16 ±
12,71 U/l), AST (125,83 ± 1,05) ve LDH (228,77 ± 14,86 U/l) konsantrasyonu yüksekti. İmmunohistokimyasal veriler tüm WMD
olgularında, dokudaki cTnI ekspresyonunda belirgin azalmanın şekillendiğine işaret ederken kontrol olarak kullanılan 8 kuzunun
hiçbirinde cTnI ekspresyonunda azalmaya rastlanmadı. Bununla beraber iNOS immunoreaktivitesi dejenere kardiyak miyositlerde ve
intersitisyumdaki makrofajlarda kontrol olgularına göre oldukça yoğundu. Sonuçlar cTnI’nın miyokardiyal hasarın ortaya
konulmasında oldukça duyarlı olarak kullanılabileceğini gösterdi. WMD’nin kardiyak miyositlerde iNOS ekspresyonunu ise arttırdığını
ortaya koydu.
Anahtar Sözcükler: Beyaz kas hastalığı, kuzu, immunohistokimya, cTnI, iNOS
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Introduction
White muscle disease (WMD) or nutritional muscular
dystrophy is most common in neonatal and fast growing
young animals and is caused by deficiency of selenium (Se)
and vitamin E (Vit E) or both (1,2). Diagnosis of WMD
relies on necropsy and clinical pathology especially
enzymes
[creatine
kinase
(CK),
aspartate
aminotransferase (AST), and lactate dehydrogenase
(LDH)] indicative of muscular dystrophy (3,4). In recent
years, use of troponin, especially cardiac troponin I (cTnI),
has gained popularity in early diagnosis of myocardial
damage (5,6). cTnI has been shown to be highly sensitive
and specific marker of myocardial damage (7). Because of
its high sensitivity and specificity to cardiac tissue, cTnI
has thus emerged as the preferred diagnostic tool and
gold standard for assessing myocardial necrosis (8). cTnI
elevates within 4-6 h after a myocardial injury in
circulation, and is superior to conventional measurement
of creatine kinase MB (CK-MB), CK, AST, and LDH for the
detection of myocardial injury as a biochemical marker
(5,6). Human cTnI assay has been validated in the
primate, pig, rat, calves, and sheep (9-11).
Nitric oxide (NO) is synthesized from L-arginine by the
action of enzyme inducible nitric oxide synthase (iNOS).
Nitric oxide synthase (NOS) is expressed either
constitutively (neuronal, type I nNOS; endothelial, type III
eNOS) or after stimulation by cytokines (inducible, type II
iNOS) (12). Inducible pathway of NO synthesis has a
biological role in the mammalian heart (12,13). Studies in
rats have demonstrated that the myocardium expressed
iNOS after treatment with cytokines. This suggests that
induction of iNOS expression in the heart may cause a
specific cardiac dysfunction observed in endotoxin shock
and certain immunological and inflammatory conditions,
including post-cardiac transplantation, myocarditis, and
ischemia-reperfusion injury, in which various cytokines
have been implicated (14,15).
In the present study, serum concentration of cTnI and
immunohistology of the cTnI and iNOS expression were
investigated to assess the significance and extend of
myocardial injury in WMD in lambs.

Materials and Methods
Animals
The study involved 15 WMD cases admitted to the
clinics of the Faculty of Veterinary Medicine between
54

2005 and 2007 and 8 healthy lambs. Clinically suspected
WMD cases were blood sampled and necropsied. Blood
samples were also collected from healthy lambs. Sera
were collected after centrifugation at 3000 rpm for 10
min and stored at -20 °C until analyses.
Serum biochemistry and cTnI analyses
Serum CK, CK-MB, AST and LDH concentrations were
determined calorimetrically using commercial kits (IBLGermany). cTnI concentration was determined using a
commercial ELISA kit (CARD-I-KIT ELISA Troponin I,
Labmaster, Finland) on an ELISA reader (Tecan-spectra,
Austria) and calculated (ng/ml) as instructed by the
manufacturer.
Necropsy and histopathology
A complete necropsy was performed on all animals.
Following the macroscopical evaluation, tissue samples
were taken from heart, diaphragm, tongue, and skeletal
muscle, and fixed in 10% buffered formalin. Selected
blocks were processed and embedded in paraffin wax.
Sections (4-6 μm) were then cut from each block for
histological examination and from only heart for
immunohistochemical analyses.
Immunohistochemistry
Sections from all heart tissue samples were cut (4-6
μm) and processed for immunohistochemical examination
by a streptavidin-biotin-peroxidase method. Tissue
sections were placed on 3-amino-propyltrieyhoxysilane
(Sigma-Aldrich, St. Louis, Montana, USA) coated slides,
dewaxed, and hydrated. Antigen retrieval was facilitated
by heating in citrate buffer (pH 6.0) for 10 min in a
microwave oven with a power of 800 watts. The slides
were then dipped in freshly prepared absolute methanol
containing hydrogen peroxide 3% v/v for 15 min to block
the endogenous peroxide activity. Next, polyclonal
antibodies were utilised: goat anti-cTnI (1:100; C-19: sc8118, Santa Cruz Biotechnology, Santa Cruz, California,
USA) and rabbit anti-iNOS (1:100; N-20: sc-651, Santa
Cruz Biotechnology). After washing with PBS, the slides
were incubated with biotinylated goat anti-rabbit
immunoglobulin G (Dako Corporation, Carpinteria, USA)
for anti-iNOS and rabbit anti-goat immunoglobulin G for
cTnI diluted at 1:300 in PBS for 30 min at room
temperature. Sections then were incubated with
streptavidin peroxidase complex (ABC; Dako Corporation,
Carpinteria, USA) diluted at 1:300 in tris-buffered
solution for 30 min at room temperature. After washing
with PBS, the slides were treated for 5 min at room
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temperature
with
3,3-diaminobenzidinetetrahydrochloride (DAB, Dako Corporation) in PBS (0.5 mg
DAB/ml) containing hydrogen peroxide 30% v/v. Finally,
sections were counterstained with Mayer's haematoxylin,
dehydrated, and mounted. Negative control tissue
sections were incubated with normal goat or rabbit serum
depending on the primary antibody utilised.
Scoring of cTnI and iNOS immunostaining results
The percentages of the total area of the cTnI and iNOS
positive cells were assessed semi-quantitatively under a
light microscope with ×10 ocular grids and ×40
objective. Positively stained cells were counted in 10
random microscopic areas and their mean was accepted as
staining score for each animal. The mean staining count
determined for each animal was also explored in statistical
analyses.
Statistical analysis
For the statistical analysis, differences between the
groups were tested by analysis of variance (ANOVA) and
Duncan test using SPSS for Windows version 10.0. Data
were presented as mean ± standard errors, and P values
less than 0.05 were considered significant.

Results
Clinical findings
The clinical signs varied from case to case. Some were
in lateral or sternal recumbency and unable to sit up with
sudden onset of dullness and respiratory distress. In some
cases the signs were stiffness, weakness, arched back,
muscle tremor when stand up, swollen muscle in gluteal,
and dorsolumbar and shoulder area on palpation. No
temperature rise was noted but most cases had elevated
heart and respiratory rates.
Biochemical and cTnI findings
Concentrations of cTnI, CK, CK-MB, AST, and LDH are
given in the Table. Serum cTnI concentration in healthy
lambs (0.32 ± 0.06 ng/ml) were significantly lower
compared to WMD cases (10.49 ± 0.25 ng/ml) (P <
0.001). Concentrations of CK, CK-MB, AST, and LDH in
WMD cases were 261.16 ± 38.61 U/l, 214.16 ± 12.71
U/l, 125.83 ± 1.05 U/l, and 228.77 ± 14.86 U/l while the
values of controls were 17.81 ± 2.27 U/l, 23.11 ± 7.05
U/l, 15.71 ± 0.94 U/l, and 125.47 ± 9.82 U/l,
respectively. The differences between the groups were
also statistically significant (P < 0.001).

Table.

Serum cTnI and biochemical changes in WMD cases and healthy
lambs. Values are presented as mean ± SE.

Parameters

WMD (n = 15)

cTnI (ng/ml)

10.49 ± 0.25

CK-MB (U/l)
CK (U/l)
AST (U/l)
LDH (U/l)

a
a

214.16 ± 12.71

a

261.16 ± 38.61
a

125.83 ± 1.05

Control (n = 8)

Significance

0.32 ± 0.06b

P < 0.001

b

P < 0.001

b

P < 0.001

b

P < 0.001

23.11 ± 7.05
17.81 ± 2.27
15.71 ± 0.94

a

228.77 ± 14.86

125.47 ± 9.82

b

P < 0.001

Different letters in rows refer to statistical difference.

Macroscopic findings
Ventricle muscles were the most severely affected part
of myocardium. Widespread lesions characterized by the
chalky-white necrosis and mineralization in the heart
muscles were seen on the interventricular septum and
particularly on the endocardial surfaces. Scattered
longitudinal striations or a pronounced chalky whiteness
like fish flesh were seen frequently on the skeletal muscle,
neck, back, gluteal muscles, tongue, and diaphragm.
Necropsy of control lambs revealed no pathological
changes in heart and skeletal muscle referring to WMD.
Microscopic findings
Microscopically, Zenker's degeneration and necrosis
were evident in the subepicardial, intramural, and
subendocardial regions of the myocardium (Figure 1a). In
some areas, the sarcoplasm exhibited dense basophilic
granules indicating presence of calcium deposition.
Bizarre and multinucleated giant cells were common and
thought to be attempts of regeneration by myocytes
(Figure 1b). Necrotic segments contained numerous
macrophages. In some areas necrotic segments were
infiltrated by proliferating fibroblasts among which newly
developing capillaries were present. Endothelial cells
located in the medial layer of some myocardial arterioles
were swelled with presence of amorphous hyaline bodies.
Zenker’s degeneration and fibrosis are common findings
for all the samples of skeletal muscles examined. Affected
fibres of the sarcoplasm with evidence of necrosis was
infiltrated with homogenous eosinophilic granules, and
many degenerated fibres were invaded by macrophages.
Other common findings were degenerated vessels with
presence of endothelial proliferation and mild fibrinoid
55
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Figure 1. Nutritional muscular dystrophy in lambs illustrated (a) as Zenker’s degeneration
and severe necrosis (nc) in the subepicardial regions of the myocardium and (b)
bizarre and multinucleated giant cells (arrow) thought to be attempts at
regeneration by myocytes are common. H&E. (Bar: a, 80 μm; b, 25 μm).

necrosis. Adventitia of large arteries were also infiltrated
by mononuclear cells.
Immunohistochemistry
The histological investigation of the samples revealed
a depletion of the cTnI in all the lamb hearts with WMD.
On the other hand, iNOS immunoreactivity was exclusively
augmented in the same samples. Figures 2 and 3 show
typical examples of the presence of iNOS and depletion of
cTnI, respectively. In normal myocardium, strong
cytoplasmic cTnI immunoreactivity was observed in the
cardiac myocytes. The semi-quantitative assessment of
cTnI and iNOS immunostaining and statistical differences
in the cardiac muscle of lambs with WMD and control
lambs are summarised in Figure 4.
Loss of cTnI immunoreactivity occurred in the cardiac
muscle cells particularly in the myocytes showing high
degree of degeneration and necrosis. Loss of cTnI tended
to be greater at the periphery of the regions rather than
at their centres.
Prominent immunostaining for iNOS was present in a
variety of cell types, including cardiac myocytes,
endocardial and endothelial cells, vascular smooth muscle
cells, and fibroblasts. Staining intensity for the iNOS
antibody was low for the myocytes exhibiting signs of
necrosis. However, iNOS immunoreactivity was
augmented in the degenerated myocytes. iNOS
56

immunoreactivity was not detected in the immature,
regenerating myocytes and myocytes with calcification. A
strong, granular type cytoplasmic iNOS reaction was
observed in the macrophages infiltrating to the
interstitium. Weak iNOS immunoreactivity was
occasionally seen in some myocytes, endocardial and
endothelial cells of control hearts.

Discussion
In the present study, elevated serum CK, CK-MB, AST,
and LDH concentrations were elevated in lambs diagnosed
with WMD following clinical findings and complete
necropsy and histopathology results. The histopathology
of affected lambs in the present study was similar to what
has previously been described in lambs with WMD (16).
Our study also demonstrated loss of tissue cTnI and
increased serum cTnI concentration in damaged
myocardial cells. cTnI was recently used as a histological
marker for myocardial injuries in human (17) and dog
(18). It has been reported that, compared to the cTnT
and cTnC, cTnI is the most specific marker for myocardial
injuries (17).
Present study indicates that immunohistochemical
staining for cTnI is more sensitive than routine H&E
staining for the recognition of myocardial necrosis.
Whenever we did observe loss of staining, there was

R. TUNCA, H. M. ERDOĞAN, M. SÖZMEN, M. ÇİTİL, A. K. DEVRİM, S. ERGİNSOY, E. UZLU

Pf

Pf

Figure 2. The cTnI immunoreactivity of the lamb heart with nutritional muscular dystrophy showing depletion (a, b, and c) of the cTnI compared
with control lambs (d). Avidin biotin peroxidase complex. (a) Normal cTnI expression in the upper left. Lower right reveals almost exclusively
loss of staining. (b) Apparent loss of cTnI immunoreactivity in the regions with severe degeneration and necrosis (arrows). (c) cTnI reaction
in Purkinje fibres (Pf). Apparent loss of cTnI in the cardiac myocytes is seen in the upper part of the figure. (d) Typical immunohistochemical
staining patterns for cTnI in normal myocardium. (Bar: a, b, c, 80 μm; d, 40 μm).

nc

Pf

Pf
Figure 3. The iNOS immunoreactivity of the lamb heart with nutritional muscular dystrophy. Prominent immunostaining for iNOS is seen in the lamb
heart with nutritional muscular dystrophy (a, b and c) compared to control (d). Avidin biotin peroxidase complex. (a) Prominent iNOS
expression is present in myocytes surrounding areas with necrosis (nc). (b) Affected myocytes reveal intense iNOS immunoreactivity. Young,
regenerating myocytes (arrow) are negative for iNOS immunostaining. (c) Weak iNOS immunoreactivity in Purkinje fibres (Pf). (d) Weak
iNOS immunoreactivity is seen in some myocytes (arrow) of control hearts. (Bar: a, b, c, d; 80 μm).
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elevation of cTnI in the blood is not the result of slow
elimination from the circulation, but rather, continuous
liberation from disintegrating myofibers (18).

























Figure 4. Semiquantitative analysis of cTnI and iNOS immunostaining
results. Values are presented as mean ± SE.

histological evidence of irreversibly injured myocytes in
the tissue. We also observed greater loss of cTnI at the
periphery of necrotic area, which likely reflects greater
antegrade and retrograde flow at the periphery with
“washout” of proteins from the necrotic myocardium
(19). Accentuation of this phenomenon with reperfusion
was previously shown in an experimental model of
myocardial ischemia in dogs. The greater loss of cTnI seen
at the periphery, especially with reperfusion, was
attributed to manifestation of this washout (18).
We observed heterogeneous loss of cTnI in necrotic
myocardium. There was a great deal of variability of
intensity of residual staining for cTnI within the necrotic
region. It is known that cardiac troponins are cleared
from the blood faster than CK-MB, but levels stay
elevated longer (20). These observations suggest
continued and/or delayed release of cTnI from the
necrotic myocytes. These findings indicate that the

In the present study the antibody generated against
human cTnI stained lamb myocardium and were
diminished in necrotic myocardium. Thus, this antibody
should be useful in studies of myocardial injury in a
variety of animal models including ruminants.
In the present study, we found an increase in iNOS
expression in lambs with WMD. In a previous study on
heart transplantation model, iNOS was induced both in
macrophages infiltrating the myocardium and in cardiac
myocytes, in response to cytokines released during the
immune response to the grafted tissue (21). Pinsky et al.
(22) showed that NO released by macrophages could kill
adjacent myocytes by an NO-dependent mechanism. They
also showed that the induction of iNOS by cytokines in
isolated purified cardiac myocytes was auto destructive to
the cardiac myocytes by an NO-dependent mechanism. It
was suggested that NO is capable of triggering apoptosis
in cardiac myocytes (23). In these studies, iNOS induction
in the myocytes suggests that NO produced by iNOS in
infiltrating macrophages and cardiac myocytes may be a
trigger for the apoptotic response of cardiac myocytes.
These results clearly suggest that iNOS expression
augments in cardiac myocytes in lambs with WMD, most
likely through influencing the signalling pathways to iNOS
induction.
In conclusion determination of serum cTnI and
immunoshistological demonstration of cTnI depletion and
iNOS expression may be of valuable diagnostic markers in
nutritional myocardial degeneration.
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